Barbara Melilli

Title: Barbara Melilli: Innovator in Ophthalmic Formulations

Introduction

Barbara Melilli is a prominent inventor based in Catania, Italy. She has made significant contributions to the field of ophthalmic formulations, particularly focusing on stability and efficacy. With a total of 2 patents, her work has the potential to enhance the quality of pharmaceutical products in eye care.

Latest Patents

Barbara Melilli's latest patents include innovative formulations that address critical needs in ophthalmology. One of her notable inventions is the "Chemically and physically stable topical ophthalmic nepafenac-based formulations." This patent provides formulations that are particularly stable from both chemical and physical perspectives. Another significant patent is for "Aqueous ophthalmic formulations based on azithromycin." This invention concerns topical ophthalmic preparations in the form of eye drops, containing azithromycin as the active ingredient. The formulations utilize β-cyclodextrins, specifically sulfobutyl ether β-cyclodextrin (SBE-β-CD), to achieve remarkable stability, allowing for storage at room temperature for the intended shelf life of commercial pharmaceutical products.

Career Highlights

Barbara Melilli is associated with Medivis S.r.l., where she continues to develop innovative solutions in the pharmaceutical industry. Her work is characterized by a commitment to improving patient care through advanced formulations.

Collaborations

Barbara collaborates with talented individuals such as Danilo Aleo and Sergio Mangiafico, contributing to a dynamic research environment that fosters innovation.

Conclusion

Barbara Melilli's contributions to ophthalmic formulations exemplify her dedication to advancing pharmaceutical science. Her innovative patents reflect her expertise and commitment to improving healthcare solutions.